Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 1.000 | |
4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.692 | |
2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.617 | |
3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.615 | |
2zva | 1N1 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.611 | |
2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.604 | |
2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.602 | |
4jq7 | KJQ | Epidermal growth factor receptor | 2.7.10.1 | 0.601 | |
4wkq | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.600 | |
4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.598 | |
4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.598 | |
4i23 | 1C9 | Epidermal growth factor receptor | 2.7.10.1 | 0.595 | |
2xyu | Q9G | Ephrin type-A receptor 4 | 2.7.10.1 | 0.594 | |
2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.589 | |
2eb3 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.585 | |
2zm1 | KSF | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.585 | |
1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.584 | |
1y57 | MPZ | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.582 | |
2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.580 | |
2itp | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.579 | |
3ad6 | KSC | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.578 | |
2itv | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.577 | |
3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.577 | |
3qlf | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.576 | |
2yn8 | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.574 | |
1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.573 | |
3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.572 | |
1byg | STU | Tyrosine-protein kinase CSK | / | 0.571 | |
2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.569 | |
2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.569 | |
4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.569 | |
3ac2 | KSE | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.568 | |
3ac3 | KSH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.568 | |
4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.568 | |
4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.567 | |
2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.566 | |
2vwu | 7X1 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.565 | |
2zm4 | KSM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.565 | |
3ag9 | A02 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.561 | |
3ac1 | KZI | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.560 | |
2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.558 | |
2itw | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.558 | |
2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.557 | |
4jq8 | KJ8 | Epidermal growth factor receptor | 2.7.10.1 | 0.557 | |
1szm | BI4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.556 | |
2zyb | KSL | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.556 | |
4jr3 | KJR | Epidermal growth factor receptor | 2.7.10.1 | 0.556 | |
3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.555 | |
3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.554 | |
4xli | 1N1 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.554 | |
3ue4 | DB8 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.553 | |
4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.553 | |
2j7t | 274 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.552 | |
2itu | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.550 | |
2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.550 | |
1jpa | ANP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.548 | |
2itx | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.547 | |
2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.547 | |
2vwx | 7X4 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.547 | |
4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.547 | |
2of4 | 979 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.545 | |
3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.545 | |
1uu8 | BI1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.544 | |
2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.544 | |
2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.544 | |
4bb4 | 32W | Ephrin type-B receptor 4 | 2.7.10.1 | 0.544 | |
3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.543 | |
4hjo | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.543 | |
3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.542 | |
3lcd | BDY | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.541 | |
4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.540 | |
4mxy | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.539 | |
4mxz | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.539 | |
4u9a | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.539 | |
4xey | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.539 | |
3qlg | 1N1 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.538 | |
1zrz | BI1 | Protein kinase C iota type | 2.7.11.13 | 0.537 | |
2itz | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.537 | |
3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.537 | |
4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.537 | |
4jrv | KJV | Epidermal growth factor receptor | 2.7.10.1 | 0.536 | |
5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.536 | |
1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.535 | |
2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.534 | |
4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.534 | |
4qmn | DB8 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.534 | |
3cd3 | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.533 | |
1oky | STU | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.531 | |
2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.530 | |
2pvy | ACP | Fibroblast growth factor receptor 2 | / | 0.530 | |
3sc1 | 3S1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.530 | |
2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.529 | |
4c02 | TAK | Activin receptor type-1 | 2.7.11.30 | 0.529 | |
4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.529 | |
4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.529 | |
4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.529 | |
2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.528 | |
2qoc | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.528 | |
3vjn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.528 | |
4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.527 | |
4mf0 | 29Z | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.527 | |
4xx9 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.527 | |
5ack | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.527 | |
2vd5 | BI8 | Myotonin-protein kinase | 2.7.11.1 | 0.526 | |
2x9f | X9F | Ephrin type-B receptor 4 | 2.7.10.1 | 0.526 | |
3ac5 | KZM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.526 | |
3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.526 | |
4ans | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.526 | |
2c0i | L1G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.525 | |
2ym4 | 4YM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.525 | |
2zv9 | PP2 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.525 | |
2hen | ADP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.524 | |
4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.524 | |
3vs3 | VSE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.523 | |
4rrv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.523 | |
5aab | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.523 | |
2py3 | ACP | Fibroblast growth factor receptor 2 | / | 0.522 | |
4qms | 1N1 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.522 | |
5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.522 | |
1qpe | PP2 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.521 | |
2r7b | 253 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.521 | |
2ym5 | YM5 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.521 | |
4c62 | XWW | Tyrosine-protein kinase JAK2 | / | 0.521 | |
4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.521 | |
5aac | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.521 | |
1okz | UCN | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.519 | |
2hy8 | 1ST | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.519 | |
2wmw | ZYW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.519 | |
2wmx | ZY6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.519 | |
4b99 | R4L | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.519 | |
1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.518 | |
3js2 | VM1 | Fibroblast growth factor receptor 1 | / | 0.518 | |
3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.518 | |
4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.518 | |
1nvq | UCN | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.517 | |
2vwz | 7X6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.517 | |
2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.517 | |
1xkk | FMM | Epidermal growth factor receptor | 2.7.10.1 | 0.516 | |
2vwy | 7X5 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.516 | |
2vx0 | 7X7 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.516 | |
2ydi | YDI | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.516 | |
2ym3 | YM3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.516 | |
3el8 | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.516 | |
1di9 | MSQ | Mitogen-activated protein kinase 14 | / | 0.515 | |
3a7h | ATP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.515 | |
3fls | FLS | Mitogen-activated protein kinase 14 | / | 0.515 | |
4cd0 | AWJ | ALK tyrosine kinase receptor | 2.7.10.1 | 0.515 | |
4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.515 | |
4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.515 | |
1uvr | BI8 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.514 | |
2cdz | 23D | Serine/threonine-protein kinase PAK 4 | 2.7.11.1 | 0.514 | |
2vww | 7X2 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.514 | |
3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.514 | |
4iwo | 1H4 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.514 | |
2wmq | ZYQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.513 | |
4ftt | 6HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.513 | |
5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.513 | |
2vwv | 7X3 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.512 | |
1e90 | MYC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.511 | |
1sm2 | STU | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.511 | |
2g2f | AGS | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.511 | |
2vx1 | 7X8 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.511 | |
2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.511 | |
3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.511 | |
4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.511 | |
4ft0 | HK9 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.511 | |
4ft7 | H3K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.511 | |
4fyn | 0VE | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.511 | |
4iwq | 1FV | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.511 | |
3cbl | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.510 | |
1uu7 | BI2 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.509 | |
2qo7 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.509 | |
2wmv | ZYV | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.509 | |
2ycq | UPX | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.509 | |
3ml8 | ML8 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.509 | |
3a62 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.508 | |
3otu | BI4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.508 | |
4c58 | 824 | Cyclin-G-associated kinase | 2.7.11.1 | 0.508 | |
4ct1 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.508 | |
2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.507 | |
2xf0 | 4UB | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.507 | |
3pvw | QRX | Beta-adrenergic receptor kinase 1 | 2.7.11.15 | 0.507 | |
3tkh | 07S | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.507 | |
3zh8 | C58 | Protein kinase C iota type | 2.7.11.13 | 0.507 | |
2ayp | 43A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.506 | |
2c0o | L2G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.506 | |
2yfx | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.506 | |
3acj | KSS | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.506 | |
3poz | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.506 | |
2a4z | BYM | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.505 | |
2f4j | VX6 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.505 | |
4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.505 | |
4dym | IYZ | Activin receptor type-1 | 2.7.11.30 | 0.505 | |
2c47 | 5ID | Casein kinase I isoform gamma-2 | / | 0.504 | |
2cgw | 3C3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.504 | |
2xck | MH4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.504 | |
3fsk | RO6 | Mitogen-activated protein kinase 14 | / | 0.504 | |
3vs0 | VS0 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.504 | |
4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.504 | |
4fsw | HK6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.504 | |
4ftl | H0K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.504 | |
4jlc | SU6 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.504 | |
1uu3 | LY4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.503 | |
1yol | S03 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.503 | |
2c3l | IDZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.503 | |
2hy0 | 306 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.503 | |
2rkv | ZBA | Trichothecene 3-O-acetyltransferase | / | 0.503 | |
2bal | PQA | Mitogen-activated protein kinase 14 | / | 0.502 | |
2biy | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.502 | |
2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.501 | |
2ycr | HCW | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.501 | |
2yir | YIR | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.501 | |
1hdc | CBO | 3-alpha-(or 20-beta)-hydroxysteroid dehydrogenase | 1.1.1.53 | 0.500 | |
2i0e | PDS | Protein kinase C beta type | 2.7.11.13 | 0.500 | |
3bbt | FMM | Receptor tyrosine-protein kinase erbB-4 | 2.7.10.1 | 0.500 | |
3el7 | PD3 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.500 | |
3vry | B43 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.500 | |
2bfy | H1N | Aurora kinase B-A | 2.7.11.1 | 0.499 | |
2j0m | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.499 | |
2jed | LG8 | Protein kinase C theta type | 2.7.11.13 | 0.499 | |
2v7a | 627 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.499 | |
3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.499 | |
3iph | G11 | Mitogen-activated protein kinase 14 | / | 0.499 | |
3tki | S25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.499 | |
3v5j | 0F2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.499 | |
4a06 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.499 | |
4fsq | HK3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.499 | |
2gs7 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.498 | |
4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.498 | |
1h1w | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.497 | |
3w2o | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.497 | |
4f63 | 0S7 | Fibroblast growth factor receptor 1 | / | 0.497 | |
4otw | DB8 | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.497 | |
2j0k | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.496 | |
2xk9 | XK9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.496 | |
4jbq | VX6 | Aurora kinase A | 2.7.11.1 | 0.496 | |
4rqk | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.496 | |
4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.496 | |
1rw8 | 580 | TGF-beta receptor type-1 | 2.7.11.30 | 0.495 | |
2wmt | ZYT | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.495 | |
2wmu | ZYU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.495 | |
2ym7 | YM7 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.495 | |
4bgg | 844 | Activin receptor type-1 | 2.7.11.30 | 0.495 | |
4rqv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.495 | |
1u54 | ACP | Activated CDC42 kinase 1 | / | 0.494 | |
2brh | DFW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.494 | |
2pzp | ACP | Fibroblast growth factor receptor 2 | / | 0.494 | |
3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 | 0.494 | |
4bc6 | XZN | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.494 | |
4f4p | 0SB | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.494 | |
4ftr | 5HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.494 | |
4qna | X11 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.494 | |
2e9n | 76A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.493 | |
3e5a | VX6 | Aurora kinase A | 2.7.11.1 | 0.493 | |
3qd3 | 3Q5 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.493 | |
1snu | STU | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.492 | |
2g2h | P16 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.492 | |
2pz5 | ACP | Fibroblast growth factor receptor 2 | / | 0.492 | |
3oom | 507 | Activin receptor type-1 | 2.7.11.30 | 0.492 | |
3pjc | PJC | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.492 | |
4ftq | 4HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.492 | |
4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.492 | |
2fgi | PD1 | Fibroblast growth factor receptor 1 | / | 0.491 | |
2pe1 | 517 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.491 | |
1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.490 | |
1vjy | 460 | TGF-beta receptor type-1 | 2.7.11.30 | 0.490 | |
2acx | ANP | G protein-coupled receptor kinase 6 | 2.7.11.16 | 0.490 | |
2brn | DF1 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.490 | |
2yiq | YIQ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.490 | |
3f5p | 741 | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.490 | |
4bdf | H3R | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.490 | |
4bdg | P3J | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.490 | |
4kba | 1QM | Casein kinase I isoform delta | 2.7.11.1 | 0.490 | |
4wbo | ANW | Rhodopsin kinase | / | 0.490 | |
1nvs | UCM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.489 | |
3dt1 | P40 | Mitogen-activated protein kinase 14 | / | 0.489 | |
3qk0 | QK0 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.489 | |
3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.489 | |
3w32 | W32 | Epidermal growth factor receptor | 2.7.10.1 | 0.489 | |
4flh | 14K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.489 | |
1bws | NDP | GDP-L-fucose synthase | / | 0.488 | |
2clq | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.488 | |
2izr | BRK | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.488 | |
3fmj | FMJ | Mitogen-activated protein kinase 14 | / | 0.488 | |
3l08 | ZIG | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.488 | |
3mvm | 39P | Mitogen-activated protein kinase 14 | / | 0.488 | |
5cvh | ADP | Casein kinase II subunit alpha | 2.7.11.1 | 0.488 | |
5hes | 032 | Mitogen-activated protein kinase kinase kinase 20 | 2.7.11.25 | 0.488 | |
1py5 | PY1 | TGF-beta receptor type-1 | 2.7.11.30 | 0.487 | |
2nry | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.487 | |
2qhm | 7CS | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.487 | |
2x8e | X8E | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.487 | |
3orz | BI4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.487 | |
4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.487 | |
4ccb | OFG | ALK tyrosine kinase receptor | 2.7.10.1 | 0.487 | |
4ftn | 2HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.487 | |
4grb | 0XG | Casein kinase II subunit alpha | 2.7.11.1 | 0.487 | |
4qmz | B49 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.487 | |
1agw | SU2 | Fibroblast growth factor receptor 1 | / | 0.486 | |
2ivv | PP1 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.486 | |
2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.486 | |
3w2r | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.486 | |
4bdh | WVI | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.486 | |
4oa9 | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.486 | |
2rl5 | 2RL | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.485 | |
2xa4 | AZ5 | Tyrosine-protein kinase JAK2 | / | 0.485 | |
3tuc | FPW | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.485 | |
4bdc | ODH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.485 | |
4fnz | NZF | ALK tyrosine kinase receptor | 2.7.10.1 | 0.485 | |
4fsz | HK8 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.485 | |
4qmt | H1N | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.485 | |
1xws | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.484 | |
3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.484 | |
3qcq | 3Q0 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.484 | |
3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.484 | |
4fhk | 0U0 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.484 | |
4i0r | 1B4 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.484 | |
4tv3 | ML9 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | / | 0.484 | |
4wh3 | ATP | N-acetylhexosamine 1-kinase | 2.7.1.162 | 0.484 | |
5c8w | PCG | cGMP-dependent protein kinase 2 | 2.7.11.12 | 0.484 | |
2cgx | 3D3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.483 | |
3hrf | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.483 | |
3iw4 | LW4 | Protein kinase C alpha type | 2.7.11.13 | 0.483 | |
3nd1 | SAH | Precorrin-6A synthase (Deacetylating) | / | 0.483 | |
3nun | JMZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.483 | |
4g6n | EK0 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.483 | |
4j95 | ACP | Fibroblast growth factor receptor 2 | / | 0.483 | |
4kb8 | 1QN | Casein kinase I isoform delta | 2.7.11.1 | 0.483 | |
1m7q | DQO | Mitogen-activated protein kinase 14 | / | 0.482 | |
2w7x | D1A | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.482 | |
3fkl | FKL | Mitogen-activated protein kinase 14 | / | 0.482 | |
4aa5 | NQB | Mitogen-activated protein kinase 14 | / | 0.482 | |
4aw0 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.482 | |
4bb5 | HD2 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.482 | |
4ftk | H9K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.482 | |
4zs2 | FLU | Alpha-ketoglutarate-dependent dioxygenase FTO | / | 0.482 | |
2buj | STU | Serine/threonine-protein kinase 16 | / | 0.481 | |
2q0b | ACP | Fibroblast growth factor receptor 2 | / | 0.481 | |
2r0u | M54 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.481 | |
2wms | ZYS | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.481 | |
2xik | J60 | Serine/threonine-protein kinase 25 | 2.7.11.1 | 0.481 | |
3c7q | XIN | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.481 | |
4gh2 | HK0 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.481 | |
2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.480 | |
2hxq | 373 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.480 | |
4b8m | VX6 | Aurora kinase B-A | 2.7.11.1 | 0.480 | |
4n6h | EJ4 | Delta-type opioid receptor | / | 0.480 | |
2qhn | 582 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.479 | |
2wou | ZZF | TGF-beta receptor type-1 | 2.7.11.30 | 0.479 | |
2zaz | GK1 | Mitogen-activated protein kinase 14 | / | 0.479 | |
3oez | STI | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.479 | |
1ir3 | ANP | Insulin receptor | 2.7.10.1 | 0.478 | |
1mqb | ANP | Ephrin type-A receptor 2 | 2.7.10.1 | 0.478 | |
1nzd | UPG | DNA beta-glucosyltransferase | / | 0.478 | |
1t88 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.478 | |
1uu9 | BI3 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.478 | |
1yw2 | PGJ | Mitogen-activated protein kinase 14 | / | 0.478 | |
2vrx | 447 | Aurora kinase B-A | 2.7.11.1 | 0.478 | |
2x7f | 824 | TRAF2 and NCK-interacting protein kinase | 2.7.11.1 | 0.478 | |
2zb0 | GK3 | Mitogen-activated protein kinase 14 | / | 0.478 | |
3cr0 | 809 | Wee1-like protein kinase | 2.7.10.2 | 0.478 | |
3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.478 | |
3oct | 1N1 | Tyrosine-protein kinase BTK | 2.7.10.2 | 0.478 | |
3u9n | 09H | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.478 | |
4c57 | FEF | Cyclin-G-associated kinase | 2.7.11.1 | 0.478 | |
4d0l | 093 | Phosphatidylinositol 4-kinase beta | 2.7.1.67 | 0.478 | |
4fsm | HK1 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.478 | |
4fta | H5K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.478 | |
4fti | H7K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.478 | |
4tuv | CPZ | Cytochrome P450 119 | 1.14 | 0.478 | |
5amn | DTQ | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.478 | |
1fm4 | DXC | Major pollen allergen Bet v 1-L | / | 0.477 | |
1zth | ADP | RIO-type serine/threonine-protein kinase Rio1 | 2.7.11.1 | 0.477 | |
2cf6 | NAP | Cinnamyl alcohol dehydrogenase 5 | 1.1.1.195 | 0.477 | |
2z2w | 770 | Wee1-like protein kinase | 2.7.10.2 | 0.477 | |
3biz | 61E | Wee1-like protein kinase | 2.7.10.2 | 0.477 | |
3f7z | 34O | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.477 | |
3gxl | QIG | TGF-beta receptor type-1 | 2.7.11.30 | 0.477 | |
3rwp | ABQ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.477 | |
3s2a | 2NQ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.477 | |
4bdb | ODO | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.477 | |
4jqe | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.477 | |
1ie4 | T44 | Transthyretin | / | 0.476 | |
1lev | CLI | Fructose-1,6-bisphosphatase 1 | 3.1.3.11 | 0.476 | |
1qbg | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.476 | |
2b1p | AIZ | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.476 | |
3q3b | 55E | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.476 | |
3q5i | ANP | Protein kinase, putative | / | 0.476 | |
3qlr | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.476 | |
3say | OFT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.476 | |
3vth | APC | Carbamoyltransferase | / | 0.476 | |
4aw5 | 30K | Ephrin type-B receptor 4 | 2.7.10.1 | 0.476 | |
4ezl | 0SE | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.476 | |
4hvg | 19Q | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.476 | |
4joa | 3DK | ALK tyrosine kinase receptor | 2.7.10.1 | 0.476 | |
4mf1 | 29Y | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.476 | |
4o70 | 1QK | Bromodomain-containing protein 4 | / | 0.476 | |
5d12 | G97 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.476 | |
5jtb | ZMA | Adenosine receptor A2a | / | 0.476 | |
1eh4 | IC1 | Casein kinase I homolog 1 | 2.7.11.1 | 0.475 | |
2cgu | 3A3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.475 | |
2yyi | FAD | 4-hydroxyphenylacetate 3-monooxygenase oxygenase component | 1.14.14.9 | 0.475 | |
3bkb | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.475 | |
4eiy | ZMA | Adenosine receptor A2a | / | 0.475 | |
4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.475 | |
4i0t | 1B6 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.475 | |
4xhg | ADP | Uncharacterized protein | / | 0.475 | |
1pkd | UCN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.474 | |
1tvo | FRZ | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.474 | |
2bxm | IMN | Serum albumin | / | 0.474 | |
3b8q | 900 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.474 | |
3ixp | 834 | Ecdysone receptor | / | 0.474 | |
3nuy | JPZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.474 | |
3vw6 | IM6 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.474 | |
4fuy | EK2 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.474 | |
4gt3 | ATP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.474 | |
1gqt | ACP | Ribokinase | / | 0.473 | |
2brm | DFZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.473 | |
2j0j | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.473 | |
2vn0 | TDZ | Cytochrome P450 2C8 | / | 0.473 | |
2w9s | TOP | Dihydrofolate reductase type 1 from Tn4003 | 1.5.1.3 | 0.473 | |
3ggf | GVD | Serine/threonine-protein kinase 26 | / | 0.473 | |
3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.473 | |
3krw | BA1 | Beta-adrenergic receptor kinase 1 | 2.7.11.15 | 0.473 | |
3qa2 | XNA | Ketohexokinase | / | 0.473 | |
4dfn | 0K1 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.473 | |
4n57 | ADP | APH(2'')-Id | / | 0.473 | |
4y8w | STR | Steroid 21-hydroxylase | / | 0.473 | |
2brg | DFY | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.472 | |
2xch | CKG | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.472 | |
2znq | 401 | Peroxisome proliferator-activated receptor delta | / | 0.472 | |
3ncg | BK1 | Calmodulin-domain protein kinase 1, putative | / | 0.472 | |
3qaq | QAQ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.472 | |
4c34 | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.472 | |
4ccu | AWF | ALK tyrosine kinase receptor | 2.7.10.1 | 0.472 | |
4lgg | VGG | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.472 | |
4qo9 | 627 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.472 | |
1h66 | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.471 | |
1stc | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.471 | |
1u59 | STU | Tyrosine-protein kinase ZAP-70 | 2.7.10.2 | 0.471 | |
2br1 | PFP | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.471 | |
2etm | 7PY | Focal adhesion kinase 1 | 2.7.10.2 | 0.471 | |
2ww4 | ADP | 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase | 2.7.1.148 | 0.471 | |
3op5 | REB | Serine/threonine-protein kinase VRK1 | 2.7.11.1 | 0.471 | |
3tdv | GDP | Gentamicin resistance protein | / | 0.471 | |
3zuy | TCH | Transporter | / | 0.471 | |
4anv | 751 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.471 | |
4aoj | V4Z | High affinity nerve growth factor receptor | 2.7.10.1 | 0.471 | |
4iar | ERM | 5-hydroxytryptamine receptor 1B | / | 0.471 | |
4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.471 | |
1kbq | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.470 | |
1lsj | NAD | Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial | 1.1.1.35 | 0.470 | |
1ouk | 084 | Mitogen-activated protein kinase 14 | / | 0.470 | |
1u3c | FAD | Cryptochrome-1 | / | 0.470 | |
2e9o | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.470 | |
2gek | GDP | Phosphatidyl-myo-inositol mannosyltransferase | 2.4.1.57 | 0.470 | |
2rbe | NDP | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.470 | |
3ds6 | A17 | Mitogen-activated protein kinase 14 | / | 0.470 | |
3hmm | 855 | TGF-beta receptor type-1 | 2.7.11.30 | 0.470 | |
3vt7 | VDX | Vitamin D3 receptor | / | 0.470 | |
4acg | 6LQ | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.470 | |
4dk5 | 0KO | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.470 | |
4e4m | 0NH | Tyrosine-protein kinase JAK2 | / | 0.470 | |
4eqc | XR1 | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.470 | |
4ftm | 1HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.470 | |
4lgh | 0JN | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.470 | |
4yuq | KS1 | Calmodulin-like domain protein kinase | / | 0.470 | |
1cqp | 803 | Integrin alpha-L | / | 0.469 | |
1pme | SB2 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.469 | |
2f4b | EHA | Peroxisome proliferator-activated receptor gamma | / | 0.469 | |
2izt | 23D | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.469 | |
3fln | 3FN | Mitogen-activated protein kinase 14 | / | 0.469 | |
3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.469 | |
3u8w | 09J | Mitogen-activated protein kinase 14 | / | 0.469 | |
3uyt | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.469 | |
4dfl | 0K0 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.469 | |
4ezk | 0SD | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.469 | |
4kbc | 1QJ | Casein kinase I isoform delta | 2.7.11.1 | 0.469 | |
4l23 | X6K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | / | 0.469 | |
5bvw | 1N1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.469 | |
5l8l | ADP | Aurora kinase A | 2.7.11.1 | 0.469 | |
1o76 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.468 | |
2wip | P49 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.468 | |
2xb7 | GUI | ALK tyrosine kinase receptor | 2.7.10.1 | 0.468 | |
2ym8 | YM8 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.468 | |
3dpd | 41A | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.468 | |
3mfs | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.468 | |
4e73 | 0NR | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.468 | |
4fv9 | E71 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.468 | |
4hgs | 15G | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.468 | |
4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.468 | |
1bsv | NDP | GDP-L-fucose synthase | / | 0.467 | |
2gqg | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.467 | |
2zba | ZBA | Trichothecene 3-O-acetyltransferase | / | 0.467 | |
3aty | FMN | Prostaglandin F2a synthase | / | 0.467 | |
3juh | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.467 | |
3mdm | FJZ | Cholesterol 24-hydroxylase | / | 0.467 | |
3r04 | UNQ | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.467 | |
3tti | KBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.467 | |
3zsi | 52P | Mitogen-activated protein kinase 14 | / | 0.467 | |
4aac | AAV | Mitogen-activated protein kinase 14 | / | 0.467 | |
4app | N53 | Serine/threonine-protein kinase PAK 4 | 2.7.11.1 | 0.467 | |
4b7t | CWT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.467 | |
4d9t | 0JG | Ribosomal protein S6 kinase alpha-3 | 2.7.11.1 | 0.467 | |
4qmy | STU | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.467 | |
1pjk | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.466 | |
2cgv | 3B3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.466 | |
2e9u | A25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.466 | |
2exc | JNK | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.466 | |
2pe2 | 464 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.466 | |
2ylx | FAD | Phenylacetone monooxygenase | 1.14.13.92 | 0.466 | |
3a1n | NAD | NDP-sugar epimerase | / | 0.466 | |
3cqe | P91 | Wee1-like protein kinase | 2.7.10.2 | 0.466 | |
3d7k | D7K | Benzaldehyde lyase | / | 0.466 | |
3kc3 | MK2 | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.466 | |
3kpz | ZNE | Vitamin D3 receptor | / | 0.466 | |
3mqe | 416 | Prostaglandin G/H synthase 2 | 1.14.99.1 | 0.466 | |
3wow | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.466 | |
4anw | O92 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.466 | |
4bcq | TJF | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.466 | |
4ckj | ADN | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.466 | |
4hle | 17V | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.466 | |
4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.466 | |
1c1d | NAI | Phenylalanine dehydrogenase | / | 0.465 | |
2bro | DF2 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.465 | |
2chx | 090 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.465 | |
2w2l | NAD | D-mandelate dehydrogenase | / | 0.465 | |
2wug | HPK | 4,5:9,10-diseco-3-hydroxy-5,9,17-trioxoandrosta-1(10),2-diene-4-oate hydrolase | 3.7.1.17 | 0.465 | |
2x2m | X2M | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.465 | |
3flk | NAI | Tartrate dehydrogenase/decarboxylase | 1.1.1.93 | 0.465 | |
3kga | LX9 | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.465 | |
3mdv | CL6 | Cholesterol 24-hydroxylase | / | 0.465 | |
3oqf | S51 | Renin | 3.4.23.15 | 0.465 | |
3r6s | CMP | CRP-like cAMP-activated global transcriptional regulator | / | 0.465 | |
4anu | EM7 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.465 | |
4aot | GW8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.465 | |
4bdi | HAU | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.465 | |
4erk | OLO | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.465 | |
4fjz | 4FJ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.465 | |
4fst | HK4 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.465 | |
4fux | E75 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.465 | |
4fw8 | NAI | 3-oxoacyl-(Acyl-carrier-protein) reductase | / | 0.465 | |
4i6a | HMG | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 1.1.1.88 | 0.465 | |
4kbk | 1QG | Casein kinase I isoform delta | 2.7.11.1 | 0.465 | |
3eml | ZMA | Adenosine receptor A2a | / | 0.465 | |
1h69 | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.464 | |
1nzf | UPG | DNA beta-glucosyltransferase | / | 0.464 | |
1ot7 | CHC | Bile acid receptor | / | 0.464 | |
1sn0 | T44 | Transthyretin | / | 0.464 | |
1xl2 | 189 | Gag-Pol polyprotein | 3.4.23.16 | 0.464 | |
1ywr | LI9 | Mitogen-activated protein kinase 14 | / | 0.464 | |
2a1n | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.464 | |
2i1m | 5CN | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.464 | |
2i40 | BLZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.464 | |
2m56 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.464 | |
2vbd | V10 | Isopenicillin N synthase | 1.21.3.1 | 0.464 | |
2yyl | FAD | 4-hydroxyphenylacetate 3-monooxygenase oxygenase component | 1.14.14.9 | 0.464 | |
3d7t | STU | Tyrosine-protein kinase CSK | / | 0.464 | |
3fwi | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.464 | |
3pre | 3RE | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.464 | |
3ztx | ZTX | Aurora kinase B-A | 2.7.11.1 | 0.464 | |
4aa4 | QC0 | Mitogen-activated protein kinase 14 | / | 0.464 | |
4bge | PYW | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.464 | |
4bkz | 1WS | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.464 | |
4c4h | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.464 | |
4cuk | NAI | D-lactate dehydrogenase | / | 0.464 | |
4f64 | 0S8 | Fibroblast growth factor receptor 1 | / | 0.464 | |
4fz6 | 0VG | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.464 | |
4uya | AGS | Mitogen-activated protein kinase kinase kinase 21 | 2.7.11.25 | 0.464 | |
5k2d | ZMA | Adenosine receptor A2a | / | 0.464 | |
2c3k | ABO | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.463 | |
2chw | 039 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.463 | |
2ham | C33 | Vitamin D3 receptor | / | 0.463 | |
2in6 | 839 | Wee1-like protein kinase | 2.7.10.2 | 0.463 | |
2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.463 | |
2p33 | J07 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.463 | |
2yyy | NAP | Glyceraldehyde-3-phosphate dehydrogenase | 1.2.1.59 | 0.463 | |
3apf | BMW | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.463 | |
3ft8 | MOJ | Heat shock protein HSP 90-alpha | / | 0.463 | |
3gfe | P37 | Mitogen-activated protein kinase 14 | / | 0.463 | |
3icr | FAD | Coenzyme A disulfide reductase | / | 0.463 | |
3kf7 | L9G | Mitogen-activated protein kinase 14 | / | 0.463 | |
4a4v | YFD | Peroxisome proliferator-activated receptor gamma | / | 0.463 | |
4eh7 | 0OO | Mitogen-activated protein kinase 14 | / | 0.463 | |
4jvb | 1M0 | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.463 | |
4k18 | 1OB | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.463 | |
4k1b | 1OC | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.463 | |
4pd6 | URI | Nucleoside permease | / | 0.463 | |
5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.463 | |
1dz6 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.462 | |
1kbo | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.462 | |
1ppj | ANY | Cytochrome b | / | 0.462 | |
2g5c | NAD | Prephenate dehydrogenase | / | 0.462 | |
2rg5 | 279 | Mitogen-activated protein kinase 14 | / | 0.462 | |
2xyn | VX6 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.462 | |
3flw | FLW | Mitogen-activated protein kinase 14 | / | 0.462 | |
3flz | FLZ | Mitogen-activated protein kinase 14 | / | 0.462 | |
3mfu | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.462 | |
3vid | 4TT | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.462 | |
4aw1 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.462 | |
4dgo | 0JW | Casein kinase II subunit alpha | 2.7.11.1 | 0.462 | |
4fsn | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.462 | |
4i6g | FAD | Cryptochrome-2 | / | 0.462 | |
4ieb | ANP | Calmodulin-domain protein kinase 1 | / | 0.462 | |
1bdm | NAX | Malate dehydrogenase | / | 0.461 | |
2c54 | NAD | GDP-mannose 3,5-epimerase | 5.1.3.18 | 0.461 | |
2phk | ATP | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 2.7.11.19 | 0.461 | |
2qg2 | A91 | Heat shock protein HSP 90-alpha | / | 0.461 | |
3m8p | 65B | Gag-Pol polyprotein | 2.7.7.49 | 0.461 | |
3nsz | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.461 | |
3uwq | U5P | Orotidine 5'-phosphate decarboxylase | / | 0.461 | |
3vt8 | YI3 | Vitamin D3 receptor | / | 0.461 | |
3wrm | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.461 | |
3zrm | ZRM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.461 | |
4a7c | E46 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.461 | |
4lsm | NAD | Glyceraldehyde-3-phosphate dehydrogenase | / | 0.461 | |
4nr4 | 2LK | CREB-binding protein | / | 0.461 | |
4xiw | AZM | Carbonic anhydrase, alpha type | / | 0.461 | |
1phg | MYT | Camphor 5-monooxygenase | 1.14.15.1 | 0.460 | |
1q3w | ATU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.460 | |
1q4l | 679 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.460 | |
1y0s | 331 | Peroxisome proliferator-activated receptor delta | / | 0.460 | |
2e9v | 85A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.460 | |
2qfx | NDP | Isocitrate dehydrogenase [NADP], mitochondrial | 1.1.1.42 | 0.460 | |
2wmr | ZYR | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.460 | |
2wxv | WXV | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.460 | |
2yer | TQ1 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.460 | |
2ym6 | YM6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.460 | |
3ckx | STU | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.460 | |
3d8b | ADP | Fidgetin-like protein 1 | 3.6.4 | 0.460 | |
3eig | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.460 | |
3fwg | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.460 | |
3ggg | NAD | Prephenate dehydrogenase | / | 0.460 | |
3il1 | B5D | Glutamate receptor 2 | / | 0.460 | |
3o15 | 3NM | Thiamine-phosphate synthase | / | 0.460 | |
3t4n | ADP | 5'-AMP-activated protein kinase subunit gamma | / | 0.460 | |
3zvv | XAZ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.460 | |
4ewq | MWL | Mitogen-activated protein kinase 14 | / | 0.460 | |
4ezj | 0SC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.460 | |
4hvi | 19S | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.460 | |
4ijp | 1EH | Serine/threonine-protein kinase PRP4 homolog | 2.7.11.1 | 0.460 | |
4jb1 | FAD | UDP-N-acetylenolpyruvoylglucosamine reductase | / | 0.460 | |
4xgx | ADP | FAD:protein FMN transferase | / | 0.460 | |
1t85 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.459 | |
1yb5 | NAP | Quinone oxidoreductase | 1.6.5.5 | 0.459 | |
2i4j | DRJ | Peroxisome proliferator-activated receptor gamma | / | 0.459 | |
2izs | BRQ | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.459 | |
2j9l | ATP | H(+)/Cl(-) exchange transporter 5 | / | 0.459 | |
2p5u | NAD | UDP-glucose 4-epimerase | / | 0.459 | |
2pzr | ACP | Fibroblast growth factor receptor 2 | / | 0.459 | |
2vgo | AD5 | Aurora kinase B-A | 2.7.11.1 | 0.459 | |
3au8 | NDP | 1-deoxy-D-xylulose 5-phosphate reductoisomerase, apicoplastic | 1.1.1.267 | 0.459 | |
3bgq | VX2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.459 | |
3fc1 | 52P | Mitogen-activated protein kinase 14 | / | 0.459 | |
3fwj | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.459 | |
3oqk | S52 | Renin | 3.4.23.15 | 0.459 | |
3qc9 | ADP | Rhodopsin kinase | / | 0.459 | |
3uim | ANP | BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 | 2.7.10.1 | 0.459 | |
4ewn | 0VR | Imidazole glycerol phosphate synthase subunit HisF | 4.1.3 | 0.459 | |
4feq | 0T8 | Tyrosine-protein kinase receptor TYRO3 | 2.7.10.1 | 0.459 | |
4ft5 | H2K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.459 | |
4lop | SB4 | Mitogen-activated protein kinase 14 | / | 0.459 | |
4m15 | ADP | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.459 | |
4r20 | AER | Cytochrome P450 family 17 polypeptide 2 | / | 0.459 | |
5k2b | ZMA | Adenosine receptor A2a | / | 0.459 | |
1dxq | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.458 | |
1i59 | ADP | Chemotaxis protein CheA | 2.7.13.3 | 0.458 | |
1j49 | NAD | D-lactate dehydrogenase | 1.1.1.28 | 0.458 | |
1zyj | BI5 | Mitogen-activated protein kinase 14 | / | 0.458 | |
2bl4 | NAD | Lactaldehyde reductase | 1.1.1.77 | 0.458 | |
2chz | 093 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.458 | |
2i4z | DRH | Peroxisome proliferator-activated receptor gamma | / | 0.458 | |
2jb4 | A14 | Isopenicillin N synthase | 1.21.3.1 | 0.458 | |
2oj9 | BMI | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.458 | |
2wti | WTI | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.458 | |
3dey | DHT | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.458 | |
3flq | 891 | Mitogen-activated protein kinase 14 | / | 0.458 | |
3frq | ERY | Erythromycin resistance repressor protein | / | 0.458 | |
3g5h | YTT | Mycocyclosin synthase | 1.14.21.9 | 0.458 | |
3i5z | Z48 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.458 | |
3klm | DHT | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.458 | |
3lqf | NAD | Galactitol dehydrogenase | / | 0.458 | |
3nmp | PYV | Abscisic acid receptor PYL2 | / | 0.458 | |
3uib | SB2 | Putative mitogen-activated protein kinase | / | 0.458 | |
3zep | 1NX | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.458 | |
4a8v | 2AN | Major pollen allergen Bet v 1-J | / | 0.458 | |
4bcm | T7Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
4fl1 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.458 | |
4g1w | G1W | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.458 | |
4jl6 | ADP | Adenylate kinase | / | 0.458 | |
4jv6 | 18F | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.458 | |
4jvf | 17X | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.458 | |
4kb8 | 1QO | Casein kinase I isoform delta | 2.7.11.1 | 0.458 | |
4kiq | 1RA | Mitogen-activated protein kinase 14 | / | 0.458 | |
1adf | TAD | Alcohol dehydrogenase E chain | 1.1.1.1 | 0.457 | |
1csn | ATP | Casein kinase I homolog 1 | 2.7.11.1 | 0.457 | |
1gjv | AGS | [3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial | 2.7.11.4 | 0.457 | |
1kgj | FL8 | Transthyretin | / | 0.457 | |
1lik | ADN | Adenosine kinase | 2.7.1.20 | 0.457 | |
1ouy | 094 | Mitogen-activated protein kinase 14 | / | 0.457 | |
1tqp | ATP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.457 | |
1u8f | NAD | Glyceraldehyde-3-phosphate dehydrogenase | 1.2.1.12 | 0.457 | |
2aa0 | MTP | Adenosine kinase | 2.7.1.20 | 0.457 | |
2b9w | FAD | Putative aminooxidase | / | 0.457 | |
2om9 | AJA | Peroxisome proliferator-activated receptor gamma | / | 0.457 | |
2ow3 | BIM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.457 | |
2wle | COA | Polysialic acid O-acetyltransferase | / | 0.457 | |
2wtc | VGM | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.457 | |
2yex | YEX | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.457 | |
3be2 | RAJ | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.457 | |
3dr8 | ACO | L-methionine sulfoximine/L-methionine sulfone acetyltransferase | / | 0.457 | |
3du8 | 553 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.457 | |
3f46 | I2C | 5,10-methenyltetrahydromethanopterin hydrogenase | 1.12.98.2 | 0.457 | |
3gwf | FAD | Cyclohexanone monooxygenase | / | 0.457 | |
3jxw | LXG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.457 | |
3mpa | SB2 | Mitogen-activated protein kinase 14 | / | 0.457 | |
3q92 | XNB | Ketohexokinase | / | 0.457 | |
3qai | XNN | Ketohexokinase | / | 0.457 | |
3sd0 | TSK | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.457 | |
4bcr | WY1 | Peroxisome proliferator-activated receptor alpha | / | 0.457 | |
4ekl | 0RF | RAC-alpha serine/threonine-protein kinase | 2.7.11.1 | 0.457 | |
4g6o | E28 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.457 | |
4i3w | NAD | Aldehyde dehydrogenase (NAD+) | / | 0.457 | |
4jlj | 1NM | Deoxycytidine kinase | 2.7.1.74 | 0.457 | |
4oh4 | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.457 | |
4uyf | 73B | Bromodomain-containing protein 2 | / | 0.457 | |
5csh | ATP | Casein kinase II subunit alpha | 2.7.11.1 | 0.457 | |
5iub | CLR | Adenosine receptor A2a | / | 0.457 | |
1aq1 | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
1bw9 | NAD | Phenylalanine dehydrogenase | / | 0.456 | |
1bxo | PP7 | Penicillopepsin-1 | 3.4.23.20 | 0.456 | |
1bxq | PP8 | Penicillopepsin-1 | 3.4.23.20 | 0.456 | |
1di8 | DTQ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
1dz8 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.456 | |
1kzj | CB3 | Thymidylate synthase | / | 0.456 | |
2a5u | QYT | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.456 | |
2c4g | 514 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
2cmv | NAP | Isocitrate dehydrogenase [NADP] cytoplasmic | 1.1.1.42 | 0.456 | |
2f2c | AP9 | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.456 | |
2has | C3O | Vitamin D3 receptor | / | 0.456 | |
2io6 | 330 | Wee1-like protein kinase | 2.7.10.2 | 0.456 | |
2p15 | EZT | Estrogen receptor | / | 0.456 | |
2wuf | KEM | 4,5:9,10-diseco-3-hydroxy-5,9,17-trioxoandrosta-1(10),2-diene-4-oate hydrolase | 3.7.1.17 | 0.456 | |
2yxu | ATP | Pyridoxal kinase | 2.7.1.35 | 0.456 | |
3b2t | M33 | Fibroblast growth factor receptor 2 | / | 0.456 | |
3f8k | COA | Uncharacterized protein | / | 0.456 | |
3had | NAD | Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial | 1.1.1.35 | 0.456 | |
3iae | D7K | Benzaldehyde lyase | / | 0.456 | |
3ibq | ATP | Pyridoxal kinase | / | 0.456 | |
3keu | ATP | Pyridoxal kinase | 2.7.1.35 | 0.456 | |
3mg3 | ECH | Orange carotenoid-binding protein | / | 0.456 | |
3nr4 | PYV | Abscisic acid receptor PYL2 | / | 0.456 | |
3qfv | NM7 | Serine/threonine-protein kinase MRCK beta | 2.7.11.1 | 0.456 | |
3r2b | 05B | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.456 | |
3sz0 | FAD | Sulfide-quinone reductase | / | 0.456 | |
3tqh | NDP | Quinone oxidoreductase | / | 0.456 | |
4i0s | 1B5 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.456 | |
4kip | 1R9 | Mitogen-activated protein kinase 14 | / | 0.456 | |
4ks7 | X4Z | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.456 | |
4oae | CLM | Uncharacterized protein | / | 0.456 | |
4v2g | ITC | Tetracycline repressor protein class D | / | 0.456 | |
4z0h | NAD | Glyceraldehyde-3-phosphate dehydrogenase GAPC1, cytosolic | 1.2.1.12 | 0.456 | |
5k2c | ZMA | Adenosine receptor A2a | / | 0.456 | |
1cm8 | ANP | Mitogen-activated protein kinase 12 | / | 0.455 | |
1hnc | GDN | Glutathione S-transferase Mu 2 | 2.5.1.18 | 0.455 | |
1k6p | XN3 | Gag-Pol polyprotein | 3.4.23.16 | 0.455 | |
1nqa | NAD | Glyceraldehyde-3-phosphate dehydrogenase | / | 0.455 | |
1rfv | ADP | Pyridoxal kinase | 2.7.1.35 | 0.455 | |
1uuo | BRF | Dihydroorotate dehydrogenase (quinone), mitochondrial | 1.3.5.2 | 0.455 | |
1yi3 | LY2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.455 | |
2gjl | FMN | Nitronate monooxygenase | 1.13.12.16 | 0.455 | |
2pyw | ADP | Methylthioribose kinase | 2.7.1.100 | 0.455 | |
2y3r | TRK | TamL | / | 0.455 | |
2ycs | NXP | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.455 | |
3ics | ADP | Coenzyme A disulfide reductase | / | 0.455 | |
3th8 | TH9 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.455 | |
3ttj | JBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.455 | |
3wmx | NAD | NAD dependent epimerase/dehydratase | / | 0.455 | |
4anx | 534 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.455 | |
4hni | 16W | Casein kinase I isoform epsilon | 2.7.11.1 | 0.455 | |
4mcb | 21W | tRNA (guanine-N(1)-)-methyltransferase | 2.1.1.228 | 0.455 | |
4otp | ADP | Serine/threonine-protein kinase RIO1 | 2.7.11.1 | 0.455 | |
4v12 | POG | MaoC like domain protein | / | 0.455 | |
1nvr | STU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.454 | |
1ork | ATC | Tetracycline repressor protein class D | / | 0.454 | |
1p31 | EPU | UDP-N-acetylmuramate--L-alanine ligase | 6.3.2.8 | 0.454 | |
1ppm | 0P1 | Penicillopepsin-1 | 3.4.23.20 | 0.454 | |
1qyw | 5SD | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.454 | |
1zar | ADP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.454 | |
2bts | U32 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
2bu9 | HFV | Isopenicillin N synthase | 1.21.3.1 | 0.454 | |
2c27 | ACO | Mycothiol acetyltransferase | 2.3.1.189 | 0.454 | |
2c3q | GTX | Glutathione S-transferase theta-1 | 2.5.1.18 | 0.454 | |
2d29 | FAD | Acyl-CoA dehydrogenase | / | 0.454 | |
2hrc | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.454 | |
2w4i | VGA | Glutamate racemase | / | 0.454 | |
2wtd | ZZK | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.454 | |
2wue | KEK | 4,5:9,10-diseco-3-hydroxy-5,9,17-trioxoandrosta-1(10),2-diene-4-oate hydrolase | 3.7.1.17 | 0.454 | |
2ydj | YDJ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.454 | |
3bhh | 5CP | Calcium/calmodulin-dependent protein kinase type II subunit beta | 2.7.11.17 | 0.454 | |
3cge | NDP | Coenzyme A disulfide reductase | / | 0.454 | |
3fly | FLY | Mitogen-activated protein kinase 14 | / | 0.454 | |
3ibe | L64 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.454 | |
3ppk | FNI | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.454 | |
3uvp | 048 | Mitogen-activated protein kinase 14 | / | 0.454 | |
3w18 | N13 | Aurora kinase A | 2.7.11.1 | 0.454 | |
4bi0 | Z0W | Dual specificity protein kinase TTK | 2.7.12.1 | 0.454 | |
4bl1 | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.454 | |
4eh6 | 0ON | Mitogen-activated protein kinase 14 | / | 0.454 | |
4fod | 0UV | ALK tyrosine kinase receptor | 2.7.10.1 | 0.454 | |
4kl9 | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.454 | |
4l04 | NAP | Isocitrate dehydrogenase [NADP] cytoplasmic | 1.1.1.42 | 0.454 | |
4nxw | ADP | Mitochondrial dynamics protein MID51 | / | 0.454 | |
4qe6 | JN3 | Bile acid receptor | / | 0.454 | |
5k2a | ZMA | Adenosine receptor A2a | / | 0.454 | |
5iua | 6DX | Adenosine receptor A2a | / | 0.454 | |
1bk0 | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.453 | |
1cjk | FOK | Adenylate cyclase type 2 | / | 0.453 | |
1cjk | FOK | Adenylate cyclase type 5 | / | 0.453 | |
1iyz | NDP | Probable quinone oxidoreductase | / | 0.453 | |
1k6t | XN1 | Gag-Pol polyprotein | 3.4.23.16 | 0.453 | |
1mja | COA | Histone acetyltransferase ESA1 | / | 0.453 | |
1nhh | ANP | DNA mismatch repair protein MutL | / | 0.453 | |
1xjd | STU | Protein kinase C theta type | 2.7.11.13 | 0.453 | |
1yrd | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.453 | |
2ejv | NAD | L-threonine 3-dehydrogenase | / | 0.453 | |
2o2u | 738 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.453 | |
2pmo | HMD | Protein kinase 7 | / | 0.453 | |
2uxu | NAR | HTH-type transcriptional regulator TtgR | / | 0.453 | |
2y46 | MIV | Mycinamicin IV hydroxylase/epoxidase | / | 0.453 | |
3bv3 | P39 | Mitogen-activated protein kinase 14 | / | 0.453 | |
3i59 | N6R | CRP-like cAMP-activated global transcriptional regulator | / | 0.453 | |
3oib | FDA | Putative acyl-CoA dehydrogenase | / | 0.453 | |
4eft | EFT | Heat shock protein HSP 90-alpha | / | 0.453 | |
4foc | 0UU | ALK tyrosine kinase receptor | 2.7.10.1 | 0.453 | |
4fsr | HKC | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.453 | |
4ftc | H6K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.453 | |
4jlo | ADP | Adenylate kinase | / | 0.453 | |
4kz0 | 1UJ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.453 | |
4xj4 | 3AT | Cyclic GMP-AMP synthase | / | 0.453 | |
4zoh | FAD | Putative oxidoreductase FAD-binding subunit | / | 0.453 | |
1cg6 | MTA | S-methyl-5'-thioadenosine phosphorylase | / | 0.452 | |
1d4a | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.452 | |
1dz4 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.452 | |
1e7q | NAP | GDP-L-fucose synthase | / | 0.452 | |
1q41 | IXM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.452 | |
1qvn | FRI | Interleukin-2 | / | 0.452 | |
2fb8 | 215 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.452 | |
2ghl | LIB | Mitogen-activated protein kinase 14 | / | 0.452 | |
2har | OCC | Vitamin D3 receptor | / | 0.452 | |
2hck | QUE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.452 | |
2jn3 | JN3 | Fatty acid-binding protein, liver | / | 0.452 | |
2x1n | X1N | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
3cs8 | BRL | Peroxisome proliferator-activated receptor gamma | / | 0.452 | |
3dga | NDP | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.452 | |
3fmn | 530 | Mitogen-activated protein kinase 14 | / | 0.452 | |
3frd | DHF | Dihydrofolate reductase | 1.5.1.3 | 0.452 | |
3k5u | PFQ | Aurora kinase A | 2.7.11.1 | 0.452 | |
3mpt | 1GK | Mitogen-activated protein kinase 14 | / | 0.452 | |
3p62 | FMN | Pentaerythritol tetranitrate reductase | / | 0.452 | |
3q9w | EMO | Casein kinase II subunit alpha | 2.7.11.1 | 0.452 | |
3t3q | 9PL | Cytochrome P450 2A6 | 1.14.13 | 0.452 | |
3vtd | TKD | Vitamin D3 receptor | / | 0.452 | |
3vwd | ACO | Alpha-tubulin N-acetyltransferase 1 | / | 0.452 | |
4a31 | 2CB | Glycylpeptide N-tetradecanoyltransferase | / | 0.452 | |
4aux | XTC | Tetracycline repressor protein class D | / | 0.452 | |
4btk | DTQ | Tau-tubulin kinase 1 | 2.7.11.1 | 0.452 | |
4dti | NAI | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.452 | |
4f65 | 0S9 | Fibroblast growth factor receptor 1 | / | 0.452 | |
4hnf | 16W | Casein kinase I isoform delta | 2.7.11.1 | 0.452 | |
4i8v | BHF | Cytochrome P450 1A1 | 1.14.14.1 | 0.452 | |
4ipw | 1G7 | Mycocyclosin synthase | 1.14.21.9 | 0.452 | |
4j03 | FVS | Bifunctional epoxide hydrolase 2 | 3.1.3.76 | 0.452 | |
4jbo | WPH | Aurora kinase A | 2.7.11.1 | 0.452 | |
4l43 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.452 | |
4l4x | NDP | AmphI | / | 0.452 | |
4l9k | EHF | Serum albumin | / | 0.452 | |
4nky | 3QZ | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.452 | |
4qmw | KS1 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.452 | |
5uvi | ZMA | Adenosine receptor A2a | / | 0.452 | |
1blz | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.451 | |
1dbv | NAD | Glyceraldehyde-3-phosphate dehydrogenase | / | 0.451 | |
1dxo | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.451 | |
1e8x | ATP | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.451 | |
1ie8 | KH1 | Vitamin D3 receptor | / | 0.451 | |
1mb9 | ATP | Carboxyethyl-arginine beta-lactam-synthase | 6.3.3.4 | 0.451 | |
1npt | NAD | Glyceraldehyde-3-phosphate dehydrogenase | / | 0.451 | |
1oiu | N76 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
1rrm | APR | Lactaldehyde reductase | 1.1.1.77 | 0.451 | |
2b9f | ADP | Mitogen-activated protein kinase FUS3 | 2.7.11.24 | 0.451 | |
2csn | CKI | Casein kinase I homolog 1 | 2.7.11.1 | 0.451 | |
2ddo | ATP | Pyridoxine/pyridoxal/pyridoxamine kinase | / | 0.451 | |
2po7 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.451 | |
2w1e | L0E | Aurora kinase A | 2.7.11.1 | 0.451 | |
2w3w | VG9 | Dihydrofolate reductase | / | 0.451 | |
3a1l | 2CC | Cytochrome P450 | / | 0.451 | |
3c0g | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.451 | |
3dhe | AND | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.451 | |
3hdm | MMG | Serine/threonine-protein kinase Sgk1 | 2.7.11.1 | 0.451 | |
3mpi | FAD | Glutaryl-CoA dehydrogenase | 1.3.99.32 | 0.451 | |
3n3z | IBM | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.451 | |
3zoi | M2W | Isopenicillin N synthase | 1.21.3.1 | 0.451 | |
3zsh | 469 | Mitogen-activated protein kinase 14 | / | 0.451 | |
4a30 | QMI | Glycylpeptide N-tetradecanoyltransferase | / | 0.451 | |
4a32 | 2CD | Glycylpeptide N-tetradecanoyltransferase | / | 0.451 | |
4b8z | NAP | GDP-L-fucose synthase | 1.1.1.271 | 0.451 | |
4bdd | Z0O | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.451 | |
4bib | IEO | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.451 | |
4bzo | 676 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.451 | |
4ftu | 7HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.451 | |
4g2l | 0WL | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.451 | |
4h3c | 0YZ | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.451 | |
4hgt | 15G | Casein kinase I isoform delta | 2.7.11.1 | 0.451 | |
4l8u | 9AZ | Serum albumin | / | 0.451 | |
4nie | NBH | Nuclear receptor ROR-gamma | / | 0.451 | |
4qkn | JMS | Alpha-ketoglutarate-dependent dioxygenase FTO | / | 0.451 | |
4ruj | VDX | Vitamin D3 receptor A | / | 0.451 | |
1gg5 | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.450 | |
1jqi | FAD | Short-chain specific acyl-CoA dehydrogenase, mitochondrial | / | 0.450 | |
1wvy | STU | Death-associated protein kinase 1 | 2.7.11.1 | 0.450 | |
2bun | FAD | AppA protein | / | 0.450 | |
2pe0 | 39Z | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.450 | |
2q59 | 240 | Peroxisome proliferator-activated receptor gamma | / | 0.450 | |
2qu6 | 857 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.450 | |
2y3s | TIR | TamL | / | 0.450 | |
2zla | VDB | Vitamin D3 receptor | / | 0.450 | |
3a14 | NDP | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | / | 0.450 | |
3cd5 | 7HI | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 1.1.1.34 | 0.450 | |
3cgd | COA | Coenzyme A disulfide reductase | / | 0.450 | |
3erk | SB4 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.450 | |
3g49 | NAP | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.450 | |
3gob | HXX | DdmC | / | 0.450 | |
3gyt | DL4 | Nuclear hormone receptor of the steroid/thyroid hormone receptors superfamily | / | 0.450 | |
3irn | 1CY | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.450 | |
3kyt | HC2 | Nuclear receptor ROR-gamma | / | 0.450 | |
3pe6 | ZYH | Monoglyceride lipase | / | 0.450 | |
3pvu | QRW | Beta-adrenergic receptor kinase 1 | 2.7.11.15 | 0.450 | |
3q4z | ANP | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.450 | |
3rpv | 26Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
3s79 | ASD | Aromatase | 1.14.14.14 | 0.450 | |
4acc | 7YG | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.450 | |
4c4i | X20 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.450 | |
4e07 | ACP | Plasmid partitioning protein ParF | / | 0.450 | |
4e5y | NDP | GDP-L-fucose synthase | 1.1.1.271 | 0.450 | |
4e8w | IHA | D-beta-D-heptose 7-phosphate kinase | / | 0.450 | |
4fad | 0TB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.450 | |
4fg7 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.450 | |
4fhi | 0S4 | Vitamin D3 receptor A | / | 0.450 | |
4hgl | 0YO | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.450 | |
4i2q | 1BT | Gag-Pol polyprotein | 2.7.7.49 | 0.450 | |
4j71 | 1JX | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.450 | |
4jld | ADP | Adenylate kinase | / | 0.450 | |
4nu5 | NAD | Phosphonate dehydrogenase | 1.20.1.1 | 0.450 | |
4oj4 | DIF | Peroxisome proliferator-activated receptor gamma | / | 0.450 | |
5a4k | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.450 | |
5dt4 | ATP | Aurora kinase A | 2.7.11.1 | 0.450 | |
5eai | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.450 | |
6cp4 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.450 | |
1ie3 | NAD | Malate dehydrogenase | / | 0.449 | |
1iid | NHM | Glycylpeptide N-tetradecanoyltransferase | 2.3.1.97 | 0.449 | |
1iol | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.449 | |
1mjb | ACO | Histone acetyltransferase ESA1 | / | 0.449 | |
1nvt | NAP | Shikimate dehydrogenase (NADP(+)) | / | 0.449 | |
1nyt | NAP | Shikimate dehydrogenase (NADP(+)) | / | 0.449 | |
1phh | FAD | p-hydroxybenzoate hydroxylase | / | 0.449 | |
1rek | B8L | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.449 | |
1w84 | L12 | Mitogen-activated protein kinase 14 | / | 0.449 | |
2bre | KJ2 | ATP-dependent molecular chaperone HSP82 | / | 0.449 | |
2cch | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
2ekl | NAD | D-3-phosphoglycerate dehydrogenase | / | 0.449 | |
2fr0 | NDP | 6-deoxyerythronolide-B synthase EryA1, modules 1 and 2 | / | 0.449 | |
2qtv | GNP | Small COPII coat GTPase SAR1 | 3.6.5 | 0.449 | |
2rc4 | ACO | Histone acetyltransferase KAT6A | / | 0.449 | |
2v9j | ATP | 5'-AMP-activated protein kinase subunit gamma-1 | / | 0.449 | |
2vmy | FFO | Serine hydroxymethyltransferase | / | 0.449 | |
2x6d | X6D | Aurora kinase A | 2.7.11.1 | 0.449 | |
3dy8 | IBM | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.449 | |
3hll | I45 | Mitogen-activated protein kinase 14 | / | 0.449 | |
3ml9 | ML9 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.449 | |
3nbw | TR4 | Ketohexokinase | / | 0.449 | |
3to6 | LYS_CMC | Histone acetyltransferase ESA1 | / | 0.449 | |
3wrh | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.449 | |
4a99 | FAD | TetX family tetracycline inactivation enzyme | / | 0.449 | |
4at0 | FAD | Possible succinate dehydrogenase | / | 0.449 | |
4bi1 | ZO6 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.449 | |
4c7k | NAP | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.449 | |
4eok | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
4ful | 0VU | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.449 | |
4g3r | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.449 | |
4kxn | 6K6 | 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 | / | 0.449 | |
4l2y | XXK | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | / | 0.449 | |
4l9i | 8PR | Rhodopsin kinase | / | 0.449 | |
4ocp | ADP | N-acetylhexosamine 1-kinase | 2.7.1.162 | 0.449 | |
4u9z | COA | Alpha-tubulin N-acetyltransferase 1 | / | 0.449 | |
5bsg | NAP | Pyrroline-5-carboxylate reductase | / | 0.449 | |
5eow | FAD | 6-hydroxynicotinate 3-monooxygenase | 1.14.13.114 | 0.449 | |
1fm6 | BRL | Peroxisome proliferator-activated receptor gamma | / | 0.448 | |
1lso | NAD | Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial | 1.1.1.35 | 0.448 | |
1osv | CHC | Bile acid receptor | / | 0.448 | |
1oz1 | FPH | Mitogen-activated protein kinase 14 | / | 0.448 | |
1rm5 | NDP | Glyceraldehyde-3-phosphate dehydrogenase A, chloroplastic | 1.2.1.13 | 0.448 | |
1s9e | ADB | Gag-Pol polyprotein | 2.7.7.49 | 0.448 | |
1tqf | 32P | Beta-secretase 1 | 3.4.23.46 | 0.448 | |
1txi | TX5 | Vitamin D3 receptor | / | 0.448 | |
1uzw | CDH | Isopenicillin N synthase | 1.21.3.1 | 0.448 | |
2bi4 | NAD | Lactaldehyde reductase | 1.1.1.77 | 0.448 | |
2c6h | PXI | Cytochrome P450 monooxygenase PikC | / | 0.448 | |
2cd8 | PXI | Cytochrome P450 monooxygenase PikC | / | 0.448 | |
2ooy | ATP | 5'-AMP-activated protein kinase subunit gamma | / | 0.448 | |
2rg6 | 287 | Mitogen-activated protein kinase 14 | / | 0.448 | |
3gxo | MQA | Mitomycin biosynthesis 6-O-methyltransferase | / | 0.448 | |
3hdh | NAD | Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial | 1.1.1.35 | 0.448 | |
3k14 | 535 | 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase | / | 0.448 | |
3kb6 | NAD | D-lactate dehydrogenase | / | 0.448 | |
3lq5 | SLQ | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.448 | |
3q9x | EMO | Casein kinase II subunit alpha | 2.7.11.1 | 0.448 | |
3ssn | MVI | Mycinamicin VI 2''-O-methyltransferase | / | 0.448 | |
3w1w | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.448 | |
4dja | FAD | (6-4) photolyase | / | 0.448 | |
4g3j | VNT | Lanosterol 14-alpha-demethylase | / | 0.448 | |
4ia3 | BIV | Vitamin D3 receptor A | / | 0.448 | |
4ite | TEY | Vitamin D3 receptor | / | 0.448 | |
4xgu | ADP | Putative pachytene checkpoint protein 2 | / | 0.448 | |
5e92 | ANP | TGF-beta receptor type-2 | 2.7.11.30 | 0.448 | |
5eb5 | FAD | (R)-mandelonitrile lyase 1 | 4.1.2.10 | 0.448 | |
1bmd | NAD | Malate dehydrogenase | / | 0.447 | |
1e7v | LY2 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.447 | |
1g4s | TPS | Thiamine-phosphate synthase | / | 0.447 | |
1h1s | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
1j39 | UPG | DNA beta-glucosyltransferase | / | 0.447 | |
1l3i | SAH | Probable cobalt-precorrin-6B C(15)-methyltransferase (decarboxylating) | / | 0.447 | |
1rby | KEU | Trifunctional purine biosynthetic protein adenosine-3 | 2.1.2.2 | 0.447 | |
1t87 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.447 | |
2aqh | NAI | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.447 | |
2bik | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.447 | |
2izu | P01 | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.447 | |
2q9f | C3S | Cholesterol 24-hydroxylase | / | 0.447 | |
2qo5 | CHD | Fatty acid-binding protein 10-A, liver basic | / | 0.447 | |
2vz6 | FEF | Calcium/calmodulin-dependent protein kinase type II subunit alpha | 2.7.11.17 | 0.447 | |
2w6n | OA2 | Biotin carboxylase | 6.3.4.14 | 0.447 | |
3be9 | P04 | Casein kinase II subunit alpha | 2.7.11.1 | 0.447 | |
3h0a | D30 | Peroxisome proliferator-activated receptor gamma | / | 0.447 | |
3hyo | ADP | Pyridoxal kinase | / | 0.447 | |
3l0l | HC3 | Nuclear receptor ROR-gamma | / | 0.447 | |
3nww | 3NW | Mitogen-activated protein kinase 14 | / | 0.447 | |
3uxy | NAD | Short-chain dehydrogenase/reductase SDR | / | 0.447 | |
3vru | YS3 | Vitamin D3 receptor | / | 0.447 | |
3zk5 | Z18 | Cytochrome P450 monooxygenase PikC | / | 0.447 | |
4akn | S5B | Bromodomain-containing protein 2 | / | 0.447 | |
4c9o | CAM | Cytochrome P450 | / | 0.447 | |
4fsy | HK7 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
4ft9 | H4K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
4g16 | 0VM | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.447 | |
4itf | TFY | Vitamin D3 receptor | / | 0.447 | |
4ix5 | ANP | Uncharacterized protein | / | 0.447 | |
4j1r | I5R | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.447 | |
4l9q | 9TP | Serum albumin | / | 0.447 | |
4mih | FAD | Pyranose 2-oxidase | 1.1.3.10 | 0.447 | |
4oav | ACP | 2-5A-dependent ribonuclease | 3.1.26 | 0.447 | |
4q71 | FAD | Bifunctional protein PutA | / | 0.447 | |
4yr9 | NAD | L-threonine 3-dehydrogenase, mitochondrial | 1.1.1.103 | 0.447 | |
5a88 | ADP | Riboflavin biosynthesis protein RibF | 2.7.1.26 | 0.447 | |
5c7o | NAD | Glyceraldehyde-3-phosphate dehydrogenase, testis-specific | 1.2.1.12 | 0.447 | |
5cds | PFB | Alcohol dehydrogenase E chain | 1.1.1.1 | 0.447 | |
5cu6 | ATP | Casein kinase II subunit alpha | 2.7.11.1 | 0.447 | |
1dnp | FAD | Deoxyribodipyrimidine photo-lyase | 4.1.99.3 | 0.446 | |
1err | RAL | Estrogen receptor | / | 0.446 | |
1fdu | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.446 | |
1hfq | MOT | Dihydrofolate reductase | 1.5.1.3 | 0.446 | |
1ie9 | VDX | Vitamin D3 receptor | / | 0.446 | |
1o97 | FAD | Electron transfer flavoprotein subunit alpha | / | 0.446 | |
1ol6 | ATP | Aurora kinase A | 2.7.11.1 | 0.446 | |
1pyx | ANP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.446 | |
1rkh | VD2 | Vitamin D3 receptor | / | 0.446 | |
1u3w | FXY | Alcohol dehydrogenase 1C | 1.1.1.1 | 0.446 | |
1u4o | NDD | L-lactate dehydrogenase | 1.1.1.27 | 0.446 | |
1zmd | NAI | Dihydrolipoyl dehydrogenase, mitochondrial | 1.8.1.4 | 0.446 | |
1zp9 | ATP | RIO-type serine/threonine-protein kinase Rio1 | 2.7.11.1 | 0.446 | |
2o0u | C0M | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.446 | |
2r0p | K2C | Putative FAD-monooxygenase | / | 0.446 | |
2tps | TPS | Thiamine-phosphate synthase | / | 0.446 | |
2xne | ASH | Aurora kinase A | 2.7.11.1 | 0.446 | |
2ycf | YCF | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.446 | |
2ydk | YDK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
2zax | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.446 | |
3a99 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.446 | |
3d84 | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.446 | |
3eem | 53V | Uncharacterized protein | / | 0.446 | |
3inm | NDP | Isocitrate dehydrogenase [NADP] cytoplasmic | 1.1.1.42 | 0.446 | |
3iok | 1P6 | Tyrosine-protein kinase JAK2 | / | 0.446 | |
3itz | P66 | Mitogen-activated protein kinase 14 | / | 0.446 | |
3kpk | FAD | Sulfide-quinone reductase | / | 0.446 | |
3qd4 | 3Q6 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.446 | |
3rus | ADP | Chaperonin | / | 0.446 | |
3tri | NAP | Pyrroline-5-carboxylate reductase | / | 0.446 | |
3zdi | UGJ | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.446 | |
3zky | WT4 | Isopenicillin N synthase | 1.21.3.1 | 0.446 | |
4c4f | 7CE | Dual specificity protein kinase TTK | 2.7.12.1 | 0.446 | |
4cfn | JYM | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
4dce | 0JF | ALK tyrosine kinase receptor | 2.7.10.1 | 0.446 | |
4ft3 | H1K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
4ia2 | BIV | Vitamin D3 receptor A | / | 0.446 | |
4kwi | 1TJ | Reductase homolog | / | 0.446 | |
4o2b | LOC | Tubulin beta-2B chain | / | 0.446 | |
4q73 | FAD | Bifunctional protein PutA | / | 0.446 | |
5c3y | AN2 | Ribokinase | / | 0.446 | |
4k5y | 1Q5 | Corticotropin-releasing factor receptor 1 | / | 0.446 | |
3pwh | ZMA | Adenosine receptor A2a | / | 0.446 | |
1cjv | FOK | Adenylate cyclase type 2 | / | 0.445 | |
1cjv | FOK | Adenylate cyclase type 5 | / | 0.445 | |
1dg8 | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.445 | |
1e3e | NAI | Alcohol dehydrogenase 4 | 1.1.1.1 | 0.445 | |
1fy7 | COA | Histone acetyltransferase ESA1 | / | 0.445 | |
1h2b | NAJ | NAD-dependent alcohol dehydrogenase | / | 0.445 | |
1m52 | P17 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.445 | |
1oec | AA2 | Fibroblast growth factor receptor 2 | / | 0.445 | |
1q5k | TMU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.445 | |
1s60 | COA | Aminoglycoside N(6')-acetyltransferase type 1 | / | 0.445 | |
1sxj | ADP | Replication factor C subunit 5 | / | 0.445 | |
1wwk | NAD | 307aa long hypothetical phosphoglycerate dehydrogenase | / | 0.445 | |
1ywn | LIF | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.445 | |
2cmw | OLP | Casein kinase I isoform gamma-1 | 2.7.11.1 | 0.445 | |
2npn | SAM | Putative cobalamin synthesis related protein | / | 0.445 | |
2p5y | NAD | UDP-glucose 4-epimerase | / | 0.445 | |
2qnq | QN3 | Gag-Pol polyprotein | 3.4.23.16 | 0.445 | |
2y1o | T26 | UDP-N-acetylmuramoylalanine--D-glutamate ligase | 6.3.2.9 | 0.445 | |
2ze2 | T27 | Gag-Pol polyprotein | 2.7.7.49 | 0.445 | |
3bxz | ADP | Protein translocase subunit SecA | / | 0.445 | |
3drc | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.445 | |
3ids | NAD | Glyceraldehyde-3-phosphate dehydrogenase, glycosomal | 1.2.1.12 | 0.445 | |
3ih0 | ANP | Uncharacterized sugar kinase PH1459 | 2.7.1 | 0.445 | |
3iw1 | ASD | Steroid C26-monooxygenase | 1.14.13.141 | 0.445 | |
3jw3 | TOP | Dihydrofolate reductase | / | 0.445 | |
3l63 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.445 | |
3pe2 | E1B | Casein kinase II subunit alpha | 2.7.11.1 | 0.445 | |
3qgt | CP6 | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.445 | |
3w0g | W07 | Vitamin D3 receptor | / | 0.445 | |
3zux | TCH | Transporter | / | 0.445 | |
4bzn | UGX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.445 | |
4ejh | 0QA | Cytochrome P450 2A13 | 1.14.14.1 | 0.445 | |
4f4d | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.445 | |
4fk3 | 325 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.445 | |
4hyh | 1AM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
4r8q | ADP | Mitotic checkpoint serine/threonine-protein kinase BUB1 | 2.7.11.1 | 0.445 | |
5ccc | DDF | Dihydrofolate reductase | 1.5.1.3 | 0.445 | |
1bdl | IM1 | Gag-Pol polyprotein | 3.4.23.16 | 0.444 | |
1gij | 2PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
1ove | 358 | Mitogen-activated protein kinase 14 | / | 0.444 | |
1rm4 | NDP | Glyceraldehyde-3-phosphate dehydrogenase A, chloroplastic | 1.2.1.13 | 0.444 | |
1svl | ADP | Large T antigen | 3.6.4 | 0.444 | |
1uye | PU9 | Heat shock protein HSP 90-alpha | / | 0.444 | |
1yp4 | ADQ | Glucose-1-phosphate adenylyltransferase small subunit, chloroplastic/amyloplastic | 2.7.7.27 | 0.444 | |
1zys | 199 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
2avv | MK1 | Gag-Pol polyprotein | 3.4.23.16 | 0.444 | |
2dwb | ANP | Aurora kinase A | 2.7.11.1 | 0.444 | |
2hw2 | RFP | Rifampin ADP-ribosyl transferase | / | 0.444 | |
2i4p | DRH | Peroxisome proliferator-activated receptor gamma | / | 0.444 | |
2iog | IOG | Estrogen receptor | / | 0.444 | |
2q61 | SF1 | Peroxisome proliferator-activated receptor gamma | / | 0.444 | |
2qbl | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.444 | |
2rgh | FAD | Alpha-Glycerophosphate Oxidase | / | 0.444 | |
2v4l | ABJ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.444 | |
2vbp | VB1 | Isopenicillin N synthase | 1.21.3.1 | 0.444 | |
2wqe | ADP | Aurora kinase A | 2.7.11.1 | 0.444 | |
2xpu | TDC | Tetracycline repressor protein class D | / | 0.444 | |
2zjw | REF | Casein kinase II subunit alpha | 2.7.11.1 | 0.444 | |
3a4v | NAD | NDP-sugar epimerase | / | 0.444 | |
3bhe | BZN | Gag-Pol polyprotein | 3.4.23.16 | 0.444 | |
3cjf | SAV | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.444 | |
3cy2 | MB9 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.444 | |
3d0b | SNX | Heat shock protein HSP 90-alpha | / | 0.444 | |
3fi3 | JK2 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.444 | |
3gb2 | G3B | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.444 | |
3m8q | DJZ | Gag-Pol polyprotein | 2.7.7.49 | 0.444 | |
3njo | P2M | Abscisic acid receptor PYR1 | / | 0.444 | |
3tdw | GDP | Gentamicin resistance protein | / | 0.444 | |
3tk3 | CPZ | Cytochrome P450 2B4 | 1.14.14.1 | 0.444 | |
3uic | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | / | 0.444 | |
3uk6 | ADP | RuvB-like 2 | 3.6.4.12 | 0.444 | |
3umx | Q18 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.444 | |
3w0c | 6DS | Vitamin D3 receptor | / | 0.444 | |
3w1f | 1O5 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.444 | |
3w5r | LOA | Vitamin D3 receptor | / | 0.444 | |
3wi6 | YRZ | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.444 | |
4afj | SJJ | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.444 | |
4cax | MYA | Glycylpeptide N-tetradecanoyltransferase | 2.3.1.97 | 0.444 | |
4egk | RDC | Heat shock protein HSP 90-alpha | / | 0.444 | |
4en4 | ATP | Pyridoxal kinase | 2.7.1.35 | 0.444 | |
4h1m | 0YJ | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.444 | |
4h4u | NDP | Biphenyl dioxygenase ferredoxin reductase subunit | / | 0.444 | |
4hw3 | 19G | Induced myeloid leukemia cell differentiation protein Mcl-1 | / | 0.444 | |
4jaz | STL | Peroxisome proliferator-activated receptor gamma | / | 0.444 | |
4lmu | QUE | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.444 | |
4nmb | FAD | Bifunctional protein PutA | / | 0.444 | |
4rup | H97 | Vitamin D3 receptor A | / | 0.444 | |
5a3b | APR | SIR2 family protein | / | 0.444 | |
5dr9 | SKE | Aurora kinase A | 2.7.11.1 | 0.444 | |
5fkn | TDC | Tetracycline repressor protein class D | / | 0.444 | |
1cx4 | CMP | cAMP-dependent protein kinase type II-beta regulatory subunit | / | 0.443 | |
1jol | FFO | Dihydrofolate reductase | 1.5.1.3 | 0.443 | |
1me8 | RVP | Inosine-5'-monophosphate dehydrogenase | / | 0.443 | |
1qcj | APT | Antiviral protein I | 3.2.2.22 | 0.443 | |
1tz8 | DES | Transthyretin | / | 0.443 | |
1ybm | NAP | Uncharacterized protein At5g02240 | / | 0.443 | |
1yin | CM3 | Estrogen receptor | / | 0.443 | |
2a1m | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.443 | |
2baq | PQB | Mitogen-activated protein kinase 14 | / | 0.443 | |
2bxn | IDB | Serum albumin | / | 0.443 | |
2gtn | LIE | Mitogen-activated protein kinase 14 | / | 0.443 | |
2j4z | 626 | Aurora kinase A | 2.7.11.1 | 0.443 | |
2jjk | R15 | Fructose-1,6-bisphosphatase 1 | 3.1.3.11 | 0.443 | |
2qbn | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.443 | |
2x7g | PVB | SRSF protein kinase 2 | 2.7.11.1 | 0.443 | |
2xm9 | LWH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.443 | |
2xpv | MIY | Tetracycline repressor protein class D | / | 0.443 | |
2y8q | ADP | 5'-AMP-activated protein kinase subunit gamma-1 | / | 0.443 | |
2zdt | 46C | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.443 | |
3ada | NAD | Subunit alpha of sarocosine oxidase | / | 0.443 | |
3f88 | 3HT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.443 | |
3fi4 | FI4 | Mitogen-activated protein kinase 14 | / | 0.443 | |
3fr8 | NDP | Ketol-acid reductoisomerase, chloroplastic | 1.1.1.86 | 0.443 | |
3gu8 | 3GU | Death-associated protein kinase 1 | 2.7.11.1 | 0.443 | |
3hk1 | B64 | Fatty acid-binding protein, adipocyte | / | 0.443 | |
3hz5 | Z64 | Heat shock protein HSP 90-alpha | / | 0.443 | |
3jyn | NDP | Quinone oxidoreductase | / | 0.443 | |
3lct | ADP | ALK tyrosine kinase receptor | 2.7.10.1 | 0.443 | |
3mvl | 38P | Mitogen-activated protein kinase 14 | / | 0.443 | |
3oro | AGS | Serine/threonine protein kinase | / | 0.443 | |
3qlx | QLR | Uncharacterized protein | / | 0.443 | |
3rv6 | VAE | Salicylate synthase | / | 0.443 | |
3v9v | 21L | Peroxisome proliferator-activated receptor gamma | / | 0.443 | |
4a9m | P9M | Bromodomain-containing protein 2 | / | 0.443 | |
4bb3 | KKA | Isopenicillin N synthase | 1.21.3.1 | 0.443 | |
4bbf | O19 | Tyrosine-protein kinase JAK2 | / | 0.443 | |
4eev | L1X | Hepatocyte growth factor receptor | 2.7.10.1 | 0.443 | |
4ejm | NAP | Putative zinc-binding dehydrogenase | / | 0.443 | |
4enh | FVX | Cholesterol 24-hydroxylase | / | 0.443 | |
4fhh | 0U3 | Vitamin D3 receptor A | / | 0.443 | |
4fx3 | 60K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
4g1z | 0VP | Vitamin D3 receptor A | / | 0.443 | |
4gb9 | 0WR | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.443 | |
4gih | 0X5 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.443 | |
4hvb | 19P | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.443 | |
4ia7 | BIV | Vitamin D3 receptor A | / | 0.443 | |
4kxl | 6C6 | 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 | / | 0.443 | |
4nb6 | 444 | Nuclear receptor ROR-gamma | / | 0.443 | |
4nh8 | 2LC | Heat shock protein HSP 90-alpha | / | 0.443 | |
4nm5 | ADP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.443 | |
4ruo | BIV | Vitamin D3 receptor A | / | 0.443 | |
4z61 | ILE_THR_GLN_TYS_TYS | Phytosulfokine receptor 1 | 2.7.11.1 | 0.443 | |
4z63 | ILE_THR_GLN_TYS_TYS | Phytosulfokine receptor 1 | 2.7.11.1 | 0.443 | |
4zca | ADP | Kinesin-like protein KIF11 | / | 0.443 | |
5c88 | COA | N-alpha-acetyltransferase | / | 0.443 | |
1hb1 | OCV | Isopenicillin N synthase | 1.21.3.1 | 0.442 | |
1hdg | NAD | Glyceraldehyde-3-phosphate dehydrogenase | / | 0.442 | |
1hqu | HBY | Gag-Pol polyprotein | 2.7.7.49 | 0.442 | |
1men | GAR | Trifunctional purine biosynthetic protein adenosine-3 | 2.1.2.2 | 0.442 | |
1oiy | N41 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
1ot7 | IU5 | Bile acid receptor | / | 0.442 | |
1qlh | NAD | Alcohol dehydrogenase E chain | 1.1.1.1 | 0.442 | |
1wlv | COA | Phenylacetic acid degradation protein PaaI | / | 0.442 | |
2bel | CBO | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.442 | |
2cvz | NDP | 3-hydroxyisobutyrate dehydrogenase | / | 0.442 | |
2ejz | SAH | Diphthine synthase | / | 0.442 | |
2fhn | BNI | Avidin-related protein 4/5 | / | 0.442 | |
2gej | GDD | Phosphatidyl-myo-inositol mannosyltransferase | 2.4.1.57 | 0.442 | |
2pmn | K51 | Protein kinase 7 | / | 0.442 | |
2qa2 | FAD | Polyketide oxygenase CabE | / | 0.442 | |
2rcy | NAP | Pyrroline-5-carboxylate reductase | / | 0.442 | |
2rio | ADP | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.442 | |
2wec | PP5 | Penicillopepsin-1 | 3.4.23.20 | 0.442 | |
2xng | A0H | Aurora kinase A | 2.7.11.1 | 0.442 | |
2xw7 | NDP | Dihydrofolate reductase | / | 0.442 | |
2yy2 | IBM | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.442 | |
3bi6 | 396 | Wee1-like protein kinase | 2.7.10.2 | 0.442 | |
3cgc | COA | Coenzyme A disulfide reductase | / | 0.442 | |
3hl7 | I47 | Mitogen-activated protein kinase 14 | / | 0.442 | |
3mfr | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.442 | |
3mzh | CMP | CRP-like cAMP-activated global transcriptional regulator | / | 0.442 | |
3nmh | PYV | Abscisic acid receptor PYL2 | / | 0.442 | |
3own | 3OW | Renin | 3.4.23.15 | 0.442 | |
3qly | 55V | Uncharacterized protein | / | 0.442 | |
3she | I85 | MAP kinase-activated protein kinase 3 | 2.7.11.1 | 0.442 | |
3tnl | NAD | Shikimate dehydrogenase (NADP(+)) | / | 0.442 | |
3tvu | B37 | Acetyl-CoA carboxylase | / | 0.442 | |
3upf | 0BU | Polyprotein | / | 0.442 | |
4aos | FAD | Steroid monooxygenase | / | 0.442 | |
4dx9 | SER_ALA_VAL_THR | Integrin beta-1 | / | 0.442 | |
4dx9 | SER_ALA_VAL_THR | Integrin beta-1-binding protein 1 | / | 0.442 | |
4fg9 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.442 | |
4fv0 | EK3 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.442 | |
4fxf | ATP | Pyruvate kinase PKM | 2.7.1.40 | 0.442 | |
4g6h | NAI | Rotenone-insensitive NADH-ubiquinone oxidoreductase, mitochondrial | 1.6.5.9 | 0.442 | |
4g7g | VFV | Lanosterol 14-alpha-demethylase | / | 0.442 | |
4idv | 13V | Mitogen-activated protein kinase kinase kinase 14 | 2.7.11.25 | 0.442 | |
4ifc | ADP | Serine/threonine-protein kinase PRP4 homolog | 2.7.11.1 | 0.442 | |
4ig0 | 1FG | Gag-Pol polyprotein | 2.7.7.49 | 0.442 | |
4ix6 | ADP | Uncharacterized protein | / | 0.442 | |
4mkh | AP5 | Adenylate kinase | / | 0.442 | |
4nxv | GDP | Mitochondrial dynamics protein MID51 | / | 0.442 | |
4wda | 2AM | 2',3'-cyclic-nucleotide 3'-phosphodiesterase | 3.1.4.37 | 0.442 | |
4y93 | 746 | Tyrosine-protein kinase | / | 0.442 | |
5br4 | NAD | Lactaldehyde reductase | 1.1.1.77 | 0.442 | |
5dr6 | SKE | Aurora kinase A | 2.7.11.1 | 0.442 | |
5hs1 | VOR | Lanosterol 14-alpha demethylase | / | 0.442 | |
5iu4 | ZMA | Adenosine receptor A2a | / | 0.442 | |
5kje | PFB | Alcohol dehydrogenase E chain | 1.1.1.1 | 0.442 | |
1a72 | PAD | Alcohol dehydrogenase E chain | 1.1.1.1 | 0.441 | |
1d3h | A26 | Dihydroorotate dehydrogenase (quinone), mitochondrial | 1.3.5.2 | 0.441 | |
1g4t | FTP | Thiamine-phosphate synthase | / | 0.441 | |
1rev | TB9 | Gag-Pol polyprotein | 2.7.7.49 | 0.441 | |
1s0z | EB1 | Vitamin D3 receptor | / | 0.441 | |
1ykf | NAP | NADP-dependent isopropanol dehydrogenase | 1.1.1.80 | 0.441 | |
2aq8 | NAI | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.441 | |
2gmj | FAD | Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial | 1.5.5.1 | 0.441 | |
2obj | VRV | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.441 | |
2oiq | STI | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.441 | |
2prh | 238 | Dihydroorotate dehydrogenase (quinone), mitochondrial | 1.3.5.2 | 0.441 | |
2qd9 | LGF | Mitogen-activated protein kinase 14 | / | 0.441 | |
2zdu | 446 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.441 | |
2znn | S44 | Peroxisome proliferator-activated receptor alpha | / | 0.441 | |
2ztv | NAD | D(-)-3-hydroxybutyrate dehydrogenase | / | 0.441 | |
3bts | NAD | Galactose/lactose metabolism regulatory protein GAL80 | / | 0.441 | |
3c50 | ADP | Rhodopsin kinase | / | 0.441 | |
3cgd | NAD | Coenzyme A disulfide reductase | / | 0.441 | |
3dmh | SAM | Probable ribosomal RNA small subunit methyltransferase | / | 0.441 | |
3et7 | 349 | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.441 | |
3fmh | 533 | Mitogen-activated protein kinase 14 | / | 0.441 | |
3ijd | C2F | Methylenetetrahydrofolate reductase | / | 0.441 | |
3l8x | N4D | Mitogen-activated protein kinase 14 | / | 0.441 | |
3lpb | NVB | Tyrosine-protein kinase JAK2 | / | 0.441 | |
3mia | ANP | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.441 | |
3ngl | NAP | Bifunctional protein FolD | / | 0.441 | |
3nwz | COA | BH2602 protein | / | 0.441 | |
3ort | AGS | Serine/threonine protein kinase | / | 0.441 | |
3p7n | FMN | Light-activated DNA-binding protein EL222 | / | 0.441 | |
3r02 | UNM | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.441 | |
3r7e | X88 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
3uoz | FAD | 2-oxo-Delta(3)-4,5,5-trimethylcyclopentenylacetyl-CoA monooxygenase | 1.14.13.160 | 0.441 | |
3v1y | NAD | Glyceraldehyde-3-phosphate dehydrogenase 1, cytosolic | 1.2.1.12 | 0.441 | |
3vt5 | YI2 | Vitamin D3 receptor | / | 0.441 | |
3vvp | BNU | Uncharacterized protein | / | 0.441 | |
4ach | KDI | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.441 | |
4b3a | TAC | Tetracycline repressor protein class D | / | 0.441 | |
4bgi | I4I | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.441 | |
4fv7 | E94 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.441 | |
4g1q | T27 | Gag-Pol polyprotein | 2.7.7.49 | 0.441 | |
4gxs | 0YS | Glutamate receptor 2 | / | 0.441 | |
4hbn | CMP | Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 | / | 0.441 | |
4hys | 1BJ | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.441 | |
4jin | 1L7 | RIO-type serine/threonine-protein kinase Rio1 | 2.7.11.1 | 0.441 | |
4kin | 1M8 | Mitogen-activated protein kinase 14 | / | 0.441 | |
4lx9 | ACO | N-alpha-acetyltransferase | 2.3.1 | 0.441 | |
4lyn | 1YG | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
4m49 | 22Y | L-lactate dehydrogenase A chain | 1.1.1.27 | 0.441 | |
4q72 | FAD | Bifunctional protein PutA | / | 0.441 | |
4ri1 | ACO | UDP-4-amino-4,6-dideoxy-N-acetyl-beta-L-altrosamine N-acetyltransferase | 2.3.1.202 | 0.441 | |
5awm | ANP | Stress-activated protein kinase JNK | 2.7.11.24 | 0.441 | |
5ecc | NAP | Dehydrofolate reductase type I | / | 0.441 | |
1eet | BFU | Gag-Pol polyprotein | 2.7.7.49 | 0.440 | |
1h73 | ANP | Homoserine kinase | 2.7.1.39 | 0.440 | |
1hk5 | T44 | Serum albumin | / | 0.440 | |
1phk | ATP | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 2.7.11.19 | 0.440 | |
1pnv | TYD | dTDP-epi-vancosaminyltransferase | 2.4.1.311 | 0.440 | |
1rkx | NAD | CDP-D-glucose-4,6-dehydratase | / | 0.440 | |
1sn5 | T3 | Transthyretin | / | 0.440 | |
1unl | RRC | Cyclin-dependent-like kinase 5 | 2.7.11.1 | 0.440 | |
1xkd | NAP | Isocitrate dehydrogenase [NADP] | / | 0.440 | |
1zg3 | 2HI | Isoflavone 4'-O-methyltransferase | / | 0.440 | |
2fsz | OHT | Estrogen receptor beta | / | 0.440 | |
2giv | ACO | Histone acetyltransferase KAT8 | / | 0.440 | |
2hr8 | SAH | Diphthine synthase | / | 0.440 | |
2i51 | FMN | Pyridoxamine 5'-phosphate oxidase-related, FMN-binding | / | 0.440 | |
2ign | FAD | Pyranose 2-oxidase | / | 0.440 | |
2ivi | ACW | Isopenicillin N synthase | 1.21.3.1 | 0.440 | |
2j2i | LY4 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.440 | |
2r43 | G3G | Gag-Pol polyprotein | 3.4.23.16 | 0.440 | |
2uxp | CLM | HTH-type transcriptional regulator TtgR | / | 0.440 | |
2v5a | LZL | Biotin carboxylase | 6.3.4.14 | 0.440 | |
2vke | TAC | Tetracycline repressor protein class D | / | 0.440 | |
2w05 | FRT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
2yke | YKE | Heat shock protein HSP 90-alpha | / | 0.440 | |
2zlc | VDX | Vitamin D3 receptor | / | 0.440 | |
2zpa | ADP | tRNA(Met) cytidine acetyltransferase TmcA | / | 0.440 | |
3amy | AGI | Casein kinase II subunit alpha | 2.7.11.1 | 0.440 | |
3c3x | NAP | Eugenol synthase 1 | 1.1.1.318 | 0.440 | |
3cuk | FAD | D-amino-acid oxidase | 1.4.3.3 | 0.440 | |
3e8e | G98 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.440 | |
3eej | 53R | Uncharacterized protein | / | 0.440 | |
3gbu | ATP | Uncharacterized sugar kinase PH1459 | 2.7.1 | 0.440 | |
3hx4 | ANP | Calmodulin-domain protein kinase 1 | / | 0.440 | |
3i8a | N22 | Dihydrofolate reductase | 1.5.1.3 | 0.440 | |
3inx | JZC | Heat shock protein HSP 90-alpha | / | 0.440 | |
3jzi | JZL | Biotin carboxylase | 6.3.4.14 | 0.440 | |
3nga | 3NG | Casein kinase II subunit alpha | 2.7.11.1 | 0.440 | |
3owj | 1EL | Casein kinase II subunit alpha | 2.7.11.1 | 0.440 | |
3owk | 18E | Casein kinase II subunit alpha | 2.7.11.1 | 0.440 | |
3owl | 19E | Casein kinase II subunit alpha | 2.7.11.1 | 0.440 | |
3p3z | P3Z | Putative cytochrome P450 | / | 0.440 | |
3vrw | YS5 | Vitamin D3 receptor | / | 0.440 | |
3zw3 | ZW3 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.440 | |
4ceq | QCH | Integrase | / | 0.440 | |
4h95 | 06U | Dihydrofolate reductase | 1.5.1.3 | 0.440 | |
4i2p | G73 | Gag-Pol polyprotein | 2.7.7.49 | 0.440 | |
4jay | FAD | UDP-N-acetylenolpyruvoylglucosamine reductase | / | 0.440 | |
4lg5 | A1O | Abscisic acid receptor PYL2 | / | 0.440 | |
4loq | SB4 | Mitogen-activated protein kinase 14 | / | 0.440 | |
4lxj | LAN | Lanosterol 14-alpha demethylase | 1.14.13.70 | 0.440 | |
4mbl | 26L | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.440 | |
4nm0 | ADP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.440 | |
4qmp | DKI | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.440 | |
4u7w | NDP | MxaA | / | 0.440 | |
5ca0 | ACP | Tubulin tyrosine ligase | / | 0.440 | |
5cp4 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.440 | |
5dju | FMN | NPH1-2 | / | 0.440 |